Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Klement Foo

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of the American Chemical Society|March 25, 2014
A mild, ferrocene-catalyzed C-H imidation of (hetero)arenesKlement Foo, Eran Sella, Isabelle Thomé, et al.
Journal of the American Chemical Society|August 20, 2021
Nickel-Catalyzed 1,2-Carboamination of Alkenyl AlcoholsTaeho Kang, Nana Kim, Peter T Cheng, et al.
Journal of Computer-Aided Molecular Design|April 24, 2025
Structure-based discovery of novel non-covalent small molecule inhibitors of USP30Padmanabhan Anbazhagan, Jothi Anantharajan, Justina Fulwood, et al.
Journal of Cheminformatics|July 7, 2026
ScrambleBench: a workflow for comparative assessment of structure-based de novo generative modelsVeincent Yap, Pan Xu, Frankie S Mak, et al.
Angewandte Chemie (International Ed. in English)|August 5, 2014
Simple sulfinate synthesis enables C-H trifluoromethylcyclopropanationRyan Gianatassio, Shuhei Kawamura, Cecil L Eprile, et al.
Nature Communications|May 15, 2025
Towards global reaction feasibility and robustness prediction with high throughput data and bayesian deep learningHaowen Zhong, Yilan Liu, Haibin Sun, et al.
Angewandte Chemie (International Ed. in English)|May 19, 2021
Strategic Design of Catalytic Lysine-Targeting Reversible Covalent BCR-ABL Inhibitors*David Quach, Guanghui Tang, Jothi Anantharajan, et al.
ACS Infectious Diseases|January 26, 2019
Targeting the Bacterial Epitranscriptome for Antibiotic Development: Discovery of Novel tRNA-(N<sup>1</sup>G37) Methyltransferase (TrmD) InhibitorsWenhe Zhong, Ann Koay, Anna Ngo, et al.
Bioorganic & Medicinal Chemistry|October 2, 2021
Fragment-based lead discovery of indazole-based compounds as AXL kinase inhibitorsPearly Shuyi Ng, Klement Foo, Sandra Sim, et al.
ACS Medicinal Chemistry Letters|June 22, 2019
Discovery of Irreversible Inhibitors Targeting Histone Methyltransferase, SMYD3Chuhui Huang, Si Si Liew, Grace R Lin, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of the American Chemical Society|March 25, 2014
A mild, ferrocene-catalyzed C-H imidation of (hetero)arenesKlement Foo, Eran Sella, Isabelle Thomé, et al.
Journal of the American Chemical Society|August 20, 2021
Nickel-Catalyzed 1,2-Carboamination of Alkenyl AlcoholsTaeho Kang, Nana Kim, Peter T Cheng, et al.
Journal of Computer-Aided Molecular Design|April 24, 2025
Structure-based discovery of novel non-covalent small molecule inhibitors of USP30Padmanabhan Anbazhagan, Jothi Anantharajan, Justina Fulwood, et al.
Journal of Cheminformatics|July 7, 2026
ScrambleBench: a workflow for comparative assessment of structure-based de novo generative modelsVeincent Yap, Pan Xu, Frankie S Mak, et al.
Angewandte Chemie (International Ed. in English)|August 5, 2014
Simple sulfinate synthesis enables C-H trifluoromethylcyclopropanationRyan Gianatassio, Shuhei Kawamura, Cecil L Eprile, et al.
Nature Communications|May 15, 2025
Towards global reaction feasibility and robustness prediction with high throughput data and bayesian deep learningHaowen Zhong, Yilan Liu, Haibin Sun, et al.
Angewandte Chemie (International Ed. in English)|May 19, 2021
Strategic Design of Catalytic Lysine-Targeting Reversible Covalent BCR-ABL Inhibitors*David Quach, Guanghui Tang, Jothi Anantharajan, et al.
ACS Infectious Diseases|January 26, 2019
Targeting the Bacterial Epitranscriptome for Antibiotic Development: Discovery of Novel tRNA-(N<sup>1</sup>G37) Methyltransferase (TrmD) InhibitorsWenhe Zhong, Ann Koay, Anna Ngo, et al.
Bioorganic & Medicinal Chemistry|October 2, 2021
Fragment-based lead discovery of indazole-based compounds as AXL kinase inhibitorsPearly Shuyi Ng, Klement Foo, Sandra Sim, et al.
ACS Medicinal Chemistry Letters|June 22, 2019
Discovery of Irreversible Inhibitors Targeting Histone Methyltransferase, SMYD3Chuhui Huang, Si Si Liew, Grace R Lin, et al.
Pageof 2